Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SCHOTT Pharma, headquartered in Germany, is a leading global partner for the pharmaceutical and biopharmaceutical industries. The company develops and manufactures innovative, high-quality primary packaging solutions made from specialty glass, including vials, syringes, and ampoules. SCHOTT Pharma ensures the safe storage and administration of medicines, prioritizing quality, patient safety, and reliability for the global healthcare sector.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SCHOTT Pharma is scheduled to report its next quarterly earnings on 12/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SCHOTT Pharma last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at 0.25 EUR.
Across its last 4 earnings reports, SCHOTT Pharma stock moved by ±3.6% on average the following day. The largest reaction was +6.4% on 02/11/2026; 3 of 4 reactions were positive.
SCHOTT Pharma has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.